Page 12 of 20

PA16.1-3 | Welcome to Acquired Haemolytic Anaemias & Smear Morphology

Learning Objectives

  • Classify acquired haemolytic anaemias by mechanism (immune vs. non-immune) and site of destruction (intravascular vs. extravascular).
  • Describe the pathogenesis of warm and cold autoimmune haemolytic anaemia (AIHA), including the role of IgG, IgM, and complement.
  • Explain the direct antiglobulin test (DAT/Coombs) — principle, interpretation, and clinical scenarios.
  • Recognise diagnostic red-cell morphologies on peripheral smear: spherocytes, schistocytes, bite cells, and RBC agglutination.
  • Outline the pathogenesis of microangiopathic haemolytic anaemia (MAHA) in TTP, HUS, and DIC.
  • Describe the role of complement dysregulation in PNH and its diagnostic marker (CD55/CD59 by flow cytometry).
  • Construct a diagnostic algorithm for a suspected haemolytic anaemia integrating DAT, smear morphology, LDH, and haptoglobin.

INSTRUCTIONS

Acquired haemolytic anaemias are encountered across specialties — from the emergency physician managing TTP to the physician encountering malaria. The unifying skill is pattern recognition: the peripheral blood smear and a single serological test (DAT) can narrow a broad differential to a specific mechanism within minutes. This module builds that skill systematically — mechanism first, morphology second, test interpretation third.

References

  • Robbins & Kumar — Basic Pathology, 11th ed., Ch. 13 (Red Cell Disorders) (textbook)
  • Harsh Mohan — Textbook of Pathology, 8th ed., Ch. 12 (textbook)
  • Wintrobe's Clinical Hematology, 14th ed., Ch. 21–22 (textbook)

Version 2.0 | NMC CBUC 2024